FinAlpha⚡

Helios Large and Midcap Fund 6 month journey - FinAlpha1Pager Celebrating its second anniversary @heliosMF , let us take a detailed look at the 6-month portfolio journey and key allocation shifts of the Helios Large & Midcap fund! 🎂 🔹 Sector Allocation & Key Shifts: • Pharmaceuticals & Biotech saw noticeable accumulation, jumping by ⬆️ 1.8%. • Finance and Banks both experienced steady additions, increasing by ⬆️ 1.1% and ⬆️ 0.9%. • Capital Markets faced the largest reduction, dropping heavily by 🔻 2.2%. • Electrical Equipment was also trimmed, sliding down by 🔻 1.8%. 🔹 Portfolio Action: • The fund maintains a controlled 30% turnover. • It recorded 20 total buys and 15 complete exits, slightly expanding the overall stock count from 57 to 59. 🔹 CAGR vs NIFTY LargeMidcap 250 TRI: • ⬆️ Strong outperformance against the benchmark across all tracked horizons, delivering an alpha of 3.4% over 3 months, 3.9% over 6 months, and 4.4% over 1 year. • Be sure to check the attached image for a detailed look at the SIP XIRR metrics!

Trust MF Small Cap Fund 6 month journey - FinAlpha1Pager Approaching its two-year anniversary soon, this fund has established itself as a standout top performer in the small-cap category since inception. @theMihirV Let us take a detailed look at its latest 6-month portfolio journey! 🚀 🔹 Sector Allocation & Key Shifts: • Pharmaceuticals & Biotech saw aggressive accumulation, jumping by ⬆️ 2.8%. • Retailing and Industrial Products both experienced solid additions, up by ⬆️ 2.4% and ⬆️ 2.0%. • Capital Markets faced a massive reduction, dropping heavily by 🔻 6.0%. • Chemicals & Petrochem and Banks were also trimmed, sliding down by 🔻 2.4% and 🔻 1.6%. 🔹 Portfolio Action: • The fund maintains an active 84% turnover. • It recorded aggressive churn with 63 total buys and 55 complete exits, expanding the overall stock count from 68 to 72. 🔹 CAGR vs NIFTY Smallcap 250 TRI: • ⬆️ Massive outperformance across all reported horizons, delivering an extraordinary alpha of 7.3% over 3 months, 13.6% over 6 months, and 23.1% over the 1-year period. • Be sure to check the attached image for a detailed look at the SIP XIRR metrics!

How was the month of October for Equity: Focused Funds? 📈 Sorted by Monthly Returns [30 Sep – 31 Oct] A divergent month for Focused funds! While broader market weakness pulled the majority of schemes into the red, high-conviction positioning paid off for several top funds that finished solidly in positive territory and comfortably beat the index. ⚖️ The benchmark index, NIFTY 500 TRI, closed the month down by -0.75%.

How was the month of October for Hybrid: Multi Asset Allocation Funds ? 📉 Sorted by Monthly Returns [30 Sep – 31 Oct] A steady display of downside defense! While broader equity markets remained soft this October, Multi Asset Allocation funds continued to cushion volatility effectively compared to pure equity categories. Edelweiss managed to hold green territory, Quantum finished flat, and top-ranking schemes significantly limited monthly drawdowns.⚖️ (Note: Please ignore the benchmark comparison for now, as a broad equity index like NIFTY 500 is not an ideal yardstick for multi-asset strategies. A custom blended benchmark for this category is currently in development.)

Helios Flexicap vs Bajaj Finserv Flexicap 📈 Portfolio Overlap Study : FinAlpha1Pager Two Flexicap funds launched just months apart - let's check their portfolio overlap and side-by-side analysis! The Data: Portfolio Overlap: 15.0% (representing 28.6% of AUM). 📊 Common Holdings: 18 shared stocks. 🤝 Top Common Stocks: Shared allocations in key high-conviction picks featuring HDFC Bank (4.31% | 5.86%), ICICI Bank (4.12% | 5.49%), and Reliance Industries (1.95% | 3.94%). Industry Overlap: 100% overlap in Commercial Services & Supplies, followed by Petroleum Products (100%) and Textiles & Apparels (50%). Concentration: Helios Flexicap allocates 34.3% to its Top 10 holdings, compared to Bajaj Finserv Flexicap at 34.1%. 🎯

Invesco Multi Asset Portfolio Update (Sep 2026) 📊 A relentless inflow deployment month at Invesco! The team executed zero fresh entries, zero exits, and zero trims instead systematically topping up 71 out of 74 holdings across the board, led by noticeable volume additions in ONGC (+1.4L shares), ITC (+1.3L shares), Coal India (+73K shares), and HDFC Bank (+24K shares). Asset Allocation Changes : Equity ⬇️ International Equity ⬇️ Reits/InvITs ⏸️ Gold ⬇️ Silver ⬇️ Debt ⬆️ 📈 71 Increase in Holdings (Including: ONGC, ITC Ltd, Coal India, HDFC Bank, Tata Steel etc.) 📉 0 Decrease in Holdings (None this month) ⏸️ 3 Companies - No Change (Held steady across 3 holdings) The fund remains broadly diversified across 70+ listings, maintaining a 46.6% domestic equity core heavily anchored by Banks (11.2%), supported by 11.7% in international equities and a solid 16.4% combined hedge in gold and silver. Detailed 1-Pager attached! 📄

Stacked chart from Jan 2018 to Oct 2026 showing how far NSE stocks sit from their 200-day average, in bands from above it (teal) to more than 20% below (red), with NIFTY 50 overlaid. Now 35% are above and 15% are more than 20% below form their 200-day average.

DSP Multi Asset Portfolio Update (Sep 2026) 📊 National Stock Exchange (NSE) officially enters the fold! DSP added IRB InvIT this month, while aggressively ramping up exposure in Hindustan Zinc (+13.1L shares). Equities and international holdings expanded across the board as debt took a backseat. Asset Allocation Changes : Equity ⬆️ International Equity ⬆️ Reits/InvITs ⬆️ Gold ⬇️ Debt ⬇️ 🟢 6 Fresh Buys (Includes: Irb Invit Fund, National Stock Exchange of India, Nuvoco Vistas, HDFC Life Insurance, Timken India, Advantest Corp) 🔴 0 Full Exits (None this month) 📈 15 Increase in Holdings (Including: Hindustan Zinc, Tata Motors, BPCL, Bharti Airtel, Larsen & Toubro etc.) 📉 1 Decrease in Holdings (Info Edge (India) Limited) ⏸️ 53 Companies - No Change (Held steady on: HDFC Bank, Axis Bank, ICICI Bank, Reliance Industries, Embassy Office Parks REIT, State Bank of India etc.) The portfolio stretches across 75 listings with total equity exposure (domestic + global) crossing 59%, while maintaining a disciplined 11.7% allocation to gold. Detailed 1-Pager attached! 📄

quant Multi Asset Portfolio Update (Sep 2026) 📊 A sharp tactical reshuffle by quant! The fund aggressively scaled up stakes in Zydus Lifesciences (+12.4L shares) and Indus Towers (+25.1L shares), while heavily paring down DLF (-9.5L shares) and Premier Energies. In commodities, they also executed an internal silver swap exiting third-party Nippon Silver into their own quant Silver ETF. Asset Allocation Changes : Equity ⬇️ Gold ⬇️ Silver ⬇️ Debt ⬇️ 🟢 0 Fresh Buys (None this month) 🔴 0 Full Exits (None this month) 📈 2 Increase in Holdings (Indus Towers Limited, Zydus Lifesciences Limited) 📉 2 Decrease in Holdings (DLF Limited, Premier Energies Limited) ⏸️ 22 Companies - No Change (Held steady on: Reliance Industries, Bharti Airtel, Adani Enterprises, Adani Green Energy, ICICI Bank, Aurobindo Pharma etc.) The portfolio stays concentrated across 26 stocks anchored by Telecom (13.0%) and Energy/Petroleum, backed by an active -14.3% equity derivatives hedge and a combined 10.7% precious metals allocation. Detailed 1-Pager attached! 📄

Jokes aside. Don't be in FOMO seeing me or anyone else buying the dip or putting in lumpsums. Act as per your plan. I can tolerate no returns for another 5 years. I have some cash flow expectations in the coming years, so I am going aggressive on equities. And it's not like I just buy mutual funds. I am running a momentum book as well, which has been 70% in cash for months, rebalancing monthly. Plus, I am trading multiple markets and generating some cash flow. Do what you've planned. Act as per your asset allocation. Don't put money into markets that you'll need in the near future. We can go much lower from here, or we can spend another 2 years in a range before the next leg of the upmove begins. Suno sabki, karo apni.

Kotak Pioneer Fund Portfolio Update (September 2026) 📊 No changes to existing names. 🟢 0 Fresh Buys (No fresh buys this month) 🔴 0 Full Exits 📉 (No exits this month) 📈 0 Increase in Holdings (No additions to existing positions this month) 📉 0 Decrease in Holdings (No trimming across existing positions this month) ⏸️ 54 Companies - No Change (Held steady on core positions: Ishares Nasdaq 100 UCITS ETF USD, Eternal Ltd, Indo-Mim Limited, Lenskart Solutions Ltd, Aster DM Quality Care Limited, etc.)

Kotak Multicap Portfolio Update (September 2026) 📊 Kotak Multicap's latest portfolio shows four fresh buys and no exits. The biggest addition was to One 97 Communications Ltd, up 1.9%. 🟢 4 Fresh Buys (Pine Labs Ltd., AXISCADES Technologies Limited, National Stock Exchange of India Ltd, CRISIL Ltd.) 🔴 0 Full Exits 📉 (No exits this month) 📈 8 Increase in Holdings (Accumulating: One 97 Communications Ltd, Maruti Suzuki India Limited, HDFC Bank Ltd, Whirlpool of India Ltd., Bank of Baroda, etc.) 📉 7 Decrease in Holdings (Includes trimming in: Indo-Mim Limited, Bharti Airtel Ltd, Mphasis Ltd, Radico Khaitan Ltd., Jubilant Pharmova Ltd, etc.) ⏸️ 53 Companies - No Change (Held steady on core positions: State Bank of India., Oracle Financial Services Software Ltd, Eternal Ltd, Hero MotoCorp Ltd., Indusind Bank Ltd., etc.)

Kotak Large and Midcap Portfolio Update (September 2026) 📊 Plenty of movement at Kotak this month: two fresh buys and two exits. The biggest addition was to Indo-Mim Limited, up 0.73%. 🟢 2 Fresh Buys (Pine Labs Ltd., One 97 Communications Ltd) 🔴 2 Full Exits 📉 (Power Grid Corporation of India Ltd., Sun TV Network Limited) 📈 5 Increase in Holdings (Accumulating: Indo-Mim Limited, Schaeffler India Ltd, Piramal Finance Ltd, Dixon Technologies India Ltd, Aster DM Quality Care Limited) 📉 4 Decrease in Holdings (Includes trimming in: Cummins India Ltd., Blue Star Ltd, ABB India Ltd., Axis Bank Ltd) ⏸️ 56 Companies - No Change (Held steady on core positions: HDFC Bank Ltd, State Bank of India., Eternal Ltd, Bharat Electronics Ltd., ICICI Bank Ltd, etc.)

Kotak AMC activity - September 2026 - based on the top 6 equity funds we track at FinAlpha. Net bought ₹2,894 Cr: ₹6,635 Cr bought against ₹3,741 Cr sold. 🔹 Top Buys & Sells Gland Pharma Limited led the purchases with an approx inflow of ₹1,063 Cr, followed by One 97 Communications Ltd at ₹921 Cr and Pine Labs Ltd. at ₹779 Cr. Other notable buys include Lenskart Solutions Ltd and Avalon Technologies Ltd. On the exit side, the AMC trimmed exposure in finance, IT - software and capital markets, specifically moving capital away from Power Finance Corporation Ltd. (₹494 Cr), Tata Consultancy Services Ltd (₹432 Cr) and BSE Ltd (₹414 Cr). 🔹 Industry Shifts The portfolio saw a clear rotation into fintech, pharma & biotech and retailing, while scaling back exposure in IT - software, diversified FMCG and industrial products. 📈 Top 5 Increased Weightage: Fintech: +0.83% Pharma & Biotech: +0.59% Industrial Manufacturing: +0.51% Retailing: +0.24% Healthcare Equipment: +0.18% 📉 Top 5 Decreased Weightage: IT - Software: -0.54% Finance: -0.42% Industrial Products: -0.37% Banks: -0.31% Capital Markets: -0.26%